Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-10-01

Clinical Trial Update: Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the immune response of UK infants to a reduced primary vaccination schedule including meningococcal C and pneumococcal conjugate vacc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Public Health England | Conditions: Pneumococcal Infections, Meningococcal Infections | Phase 4 | Status: COMPLETED